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Abstract
Background: Dendritic cells (DCs) as professional antigen presenting cells (APCs) play a critical role in the regulation
of host immune responses. DCs evolve from immature, antigen-capturing cells, to mature antigen-presenting
cells. The relative contribution of DCs to cigarette smoke-induced inflammation is not well documented. In
the current study, we investigated a modulatory effect of cigarette smoke extract (CSE) on differentiation,
maturation and function of DCs.
Methods: Primary murine DCs were grown from bone marrow cells with GM-CSF. Development of DC was
analyzed by expression of CD11c, MHCII, CD86, CD40 and CD83 using flow cytometry. Murine DC’s and
human L428 cells were co-cultured with CSE for various periods of time. Functional activity was analyzed by
measuring FITC-dextran uptake, cytokine production and the ability to stimulate T cell activation in a mixed
lymphocyte reaction.
Results: Our results show that short-term CSE stimulation (~24 h) influence the maturation status of newly
differentiated and immature DCs towards more mature cells as revealed by upregulation of MHCII, CD83,
CD86, CD40, reduction in antigen up-take capacity and enhanced secretion of pro-inflammatory (IL-12, IL-6
and TNF-α) cytokines. Interestingly, long-term CSE exposure, time- and concentration-dependently, suppressed
the development of functional DCs. This suppression was demonstrated by a decline in CD11c/MHCII, CD83,
CD86 and CD40 expression, the production of cytokines and ability to stimulate T lymphocytes. Moreover, CSE
significantly suppressed the endocytosis function of mouse DCs which was not due to diminished DC viability. Similar
to mouse DCs, long-term co-culturing of the human L428 DC cell line with CSE time-dependently suppressed the
expression of CD54.
Conclusions: The present study provides evidence that CSE modulates DC-mediated immune responses via affecting
both the function and maturation of DCs. The suppressive effects of cigarette smoke on DC function might lead to
impaired immune responses to various infections.
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Background
Cigarette smoking is the main risk factor for the devel-
opment of inflammatory lung disease such as chronic
obstructive pulmonary disease (COPD) which is a slowly
progressive disease [1]. The lung inflammatory response
to CS exposure is complex and mechanisms initiating
this response are still poorly understood. It has been
shown that cigarette smoke (CS) contains a complex
mixture of chemicals, bacterial and fungal components
including LPS [2] that are capable of exerting immune-
modulating effects. Thus, understanding in detail the
mechanisms underlying inflammatory process induced
by CS may lead to better therapeutic approaches in
COPD. Many inflammatory cells and their mediators,
both of the innate and adaptive immune system, play a
role in the pathogenesis of disease [3]. Macrophages,
neutrophils and lymphocyte are the cells usually consid-
ered the prime effector cells in immune response to CS,
but recently DCs have been suggested to be a potentially
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important new player/orchestrator of the pattern of in-
flammation induced by CS [4].
DCs are essential antigen-presenting cells (APCs) and
orchestrate innate inflammatory responses and adaptive
immunity through activation of T cells via direct cell-cell
interactions and/or cytokine production [5, 6]. In both
humans and mice there are several subtypes of DC, as
characterized by surface markers and function. Gener-
ally, DC subsets arise from bone marrow (BM) precur-
sors that colonize peripheral tissues through blood or
the lymphatic system [6–9]. Pulmonary DCs distribute
in sub-epithelial, interstitial and pleural compartments
where they usually exist as immature antigen presenting
cells. Immature DCs are efficient in antigen uptake, but
during DC maturation antigen uptake ability decreases
as the antigen presenting ability is enhanced. MHCII
molecules present the first classical signal in the process
of antigen presentation, and co-stimulatory molecules
such as CD86, CD40 represent the second signal. Since
DCs are so well equipped to initiate adaptive immune
responses, they are considered prime targets for modu-
lating immune responses.
The number of DCs in vivo is low compared with
most other immune cells, and their isolation in sufficient
numbers for comprehensive studies is laborious and
expensive. Therefore, the majority of studies use in vitro
generated DCs from bone marrow cells or blood mono-
cyte [10–13].
Studies using bone marrow and monocyte-derived
DCs exposed to varying concentrations of cigarette
smoke extract (CSE) and nicotine yielded contrasting re-
sults with respect to the effects on DC function [14–17].
The importance of DCs in maintaining host immunity




CSE was produced following the method as described
before [18]. Briefly CSE was generated by the burning
of commercially available Lucky Strike cigarettes with-
out filter (British–American Tobacco, Groningen, The
Netherlands), using the TE-10z smoking machine
(Teague Enterprises, Davis, CA, USA), which is pro-
grammed to smoke cigarettes according to the Federal
Trade Commission protocol (35-ml puff volume
drawn for 2 s, once per minute). This machine was
used to direct main- and side-stream smoke from one
cigarette through a 5-ml culture medium (RPMI with-
out phenol red). Hereafter, absorbance was measured
with a spectrophotometer, and the media were stan-
dardized to a standard curve of CSE concentration
against absorbance at 320 nm. The pH of the result-
ant extract was titrated to pH 7.4 and diluted with
medium. This concentration (optical density (OD) = 4.0)
was serially diluted with untreated media to 0.5–3 % OD
and used in the indicated experiments.
Cell preparation and experimental design
Culture of mouse BMDCs
The method for generating BM-derived DCs was adapted
from that described by Lutz and coworkers [19] with
slight modifications. The use of animals in these studies
was approved by the animal ethics committee of the
Utrecht University. BM cells isolated from BALB/c mice
(4-to 12-week-old) and were cultured in complete RPMI
1640 supplemented with GM-CSF 200u/ml (=20 ng/ml)
for 10 days. In order to investigate how CSE influenced
full maturation of DCs, the non-adherent cells were incu-
bated with CSE (0.05–1.5 %) or LPS (0.01–1 μg/ml, as
positive control) for the final 24 h of culture period or the
next 18 h after the culture period (Fig. 1a). Subsequently,
to evaluate the immune modulatory effect of CSE on DCs
differentiation process, BM cells were cultured in the
presence or absence of CSE (0–1.5 %) or LPS (0.01–1 μg/
ml) from day 0 for 10 days (Fig. 1b). To investigate the
effect of timing of the CSE exposure in the differentiation
of BM precursors to DCs, cells were co-cultured with CSE
(1.5 %) or LPS (100 ng/ml) at various time points of
culture at from day 3 or day 6 for 7 or 4 days in parallel
experiments (Fig. 1c). Non adherent and loosely adherent
cells were harvested for analysis. DCs responses were
assayed using ELISA (cytokine production) and flow
cytometry analysis (surface marker expression). Nontoxic
effects of up to 1.5 % concentration of CSE was found
since viability were consistently established to be >95 %
(trypan blue exclusion).
Mixed lymphocyte reaction
To assess the function of CSE and LPS-stimulated
BMDCs the mixed lymphocyte reaction (MLR) was used.
Briefly, spleens from D011.10 TAC (kindly provided by
dr Janneke Samson, EUR, Rotterdam, the Netherlands)
were prepared and CD4 + KJ1.26+ T cells were isolated
using a CELLection Biotin Binder kit isolation kit (Life
Technologies) according to manufacturer’s instructions.
Freshly isolated T cells were stained with 5, 6-carboxy-
succinimidyl-fluorescein-ester dye (CFSE) (CellTrace™
CFSE Cell Proliferation Kit, Life Technologies) and co-
cultured with BMDCs at a DC:T cell ratio of 1:5, 1:10
and 1:20 in presence of ovalbumin protein in round-
bottom 96-well microtiter plates for 72 h. At the end of
72 h, supernatant and cells were collected for cytokine
measurement (IL −6, −10, −12p70 and IFN-γ) using a
cytometric bead array kit (BD CBA Flex Sets) and T cell
proliferation was measured by flow cytometry using a
BD FACS CantoII flow cytometer.
Givi et al. Respiratory Research  (2015) 16:131 Page 2 of 10
Culture of L428 cells
The Hodgkin’s disease (HD)-derived cell line L428 most
closely resembles a human DCs phenotype and function
[20, 21]. Thus, L428 (kindly provided by University of
California) was used in this experiment as a human-DC
model to determine the long-term effect of CSE on hu-
man DCs activation. Cells were maintained at 4 × l06 to
2 × 106 cells/ mL in RPMI-1640 supplemented with
10 % FBS, L-glutamine (2 mM), penicillin (100 U/ml),
streptomycin (100 mg/ml), 2-mercaptoethanol (50 μmol/L)
and gentamicin (50 μg/mL) at 37 °C in a humidified
5 % CO2 atmosphere. The medium was replenished
twice weekly, 24–48 h prior to assay. The viability of
these cells was maintained at >95 % (Trypan Blue dye
exclusion). These cells have a doubling time of approxi-
mately 60 to 84 h. Following the third subconfluent
passage, cells were cultured in the presence or absence
of CSE (1.5 %) or LPS (100 ng/ml) for periods of 10, 20
and 30 days. At the end of each experimental period,
non-adherent and loosely adherent cells were harvested
for FACS analysis.
Flow cytometry analysis
Surface receptor expression on mouse and L428 DCs
was determined by FACS analysis. To this end, cells
were washed once with 1x PBS/0.3 % BSA and stained
with primary antibodies directly conjugated to fluoro-
chromes for 30 min at 4oC. Dead cells were excluded
using annexin-V and 7-AAD (BD Biosciences) viability
staining. Live events were acquired on a FACSCanto
II flow cytometer (BD Biosciences), and data were an-
alyzed with FACSDiva software (v6.1.2). The following
antibodies were used for flow cytometry analysis: PE-
Cy7–conjugated anti-mouse CD11c, FITC-conjugated
anti–major histocompatibility complex (MHC) class
II, PE-conjugated anti-mouse CD86, APC-conjugated
anti-mouse-CD40 and -CD83 and PE-conjugated anti-
human CD54. All antibodies were purchased from
eBioscience or BD Biosciences (San Diego, CA).
FITC–dextran uptake
To assess DC endocytic activity, BMDCs were sus-
pended in RPMI 1640 supplemented with 10 % FCS and
incubated with 1 mg/ml of FITC–dextran (Fluorescein
isothiocyanate-labeled dextrans) (Mr = 40,500; Sigma
Aldrich, the Netherlands) for 30 min at 4 or 37 °C. Cells
were washed three times with ice-cold PBS, 0.1 % BSA
and 0.01 % NaN3, and labeled on ice with appropriate
mAb. The uptake was calculated as the change in mean
fluorescence intensity (MFI) between cell samples incu-
bated at 37 and 4 °C.
Cytokine assay
The inflammatory cytokines; IL-12, IL-6 and TNF-α,
were quantified at the protein level in supernatants of








Fig. 1 Experimental design diagram: Generation of BM-derived DCs with GM-CSF in presence or absence of CSE during 10 days. The cultures
were re-cultured with fresh medium containing GM-CSF (20 ng/ml) at days 0, 3, 6 and 8. a In order to investigate the acute effects of CSE on the
full maturation of DCs, cells were incubated with CSE (0.05–1.5 %) or LPS (0.01–1 μg/ml, as positive control) for the final 24 h of culture period or
the next 18 h after the culture period. b To evaluate the prolonged immune modulatory effect of CSE on DCs differentiation process, BM cells
were cultured in the presence or absence of CSE (0–1.5 %) or LPS (0.01–1 μg/ml) from day 0 for 10 days. c To investigate timing effect of CS
exposure in the differentiation of BM precursors to DCs, cells were co-cultured with CSE (1.5 %) or LPS (100 ng/ml) at various time points
of culture from day 3 or day 6 for 7 or 4 days in parallel experiments. *Indicate administration of CSE or LPS
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Statistical analysis
Experimental results are expressed as mean ± S.E.M.
Results were tested statistically by a one-way ANOVA
followed by Newman-Keuls test for comparing all pairs of
groups or two-tailed, non-paired, student’s t-test. Analyses
were performed using GraphPad Prism (version 5.0). Re-
sults were considered statistically significant when P < 0.05.
Results
CSE effects on DC maturation during short-term and
long-term incubation
In order to investigate the acute effects of CSE on the
full maturation of DCs, BMDCs were incubated with
CSE (0.05–1.5 %) or LPS (0.01–1 μg/ml, as positive con-
trol) for 18 h after 10 days of culture (Fig. 1a). CSE in-
creased CD11c and MHCII expression, concentration
dependently (Fig. 2a). Further experiments were per-
formed with a CSE concentration of 1.5 % since higher
concentrations were toxic.
Next, we examined the effect of short-term culturing
of DCs with CSE for the final 24 h of the 10 days cultur-
ing period (Fig. 1a). Consistent with an increased matur-
ation, CSE induced the expression of CD11c, MHCII
(Fig. 2b), the co-stimulatory molecules CD86, CD40
(Fig. 2b) and CD83 (Fig. 2c). To test the long-term CSE
effects on DC maturation, DC precursors were cultured
in the presence of CSE for 10 days (Fig. 1b). In contrast
to short exposure time, long-term incubation with CSE
resulted in a suppression of CD11c-MHCII/CD83 ex-
pression (Fig. 2c).
CSE increased the developing of defective and silent DCs
during long-term stimulation
To examine whether CSE influenced the development of
DCs from BM precursors, isolated BM cells were cultured
in the presence or absence of CSE or LPS continuously
(Fig. 1b). At the end of day 10, the non-adherent and
loosely adherent cells were analyzed for the expression of
Fig. 2 CSE induces DC maturation during short-term stimulation. Representative histograms (left panel) showing the expression of the cell surface
DC maturation markers CD11c, MHCII and CD83. Bar graphs (right panel) represent expression of CD11c-MHCII and co-stimulatory molecules
CD86, CD40 as percentage of positive DCs. BMDCs were cultured with (a) CSE (0.05–1.5 %) or LPS (0.01–1 μg/ml, as a positive control) for 18 h, (b) CSE
(1.5 %) or LPS (1 μg) for final 24 h and (c) CSE (1.5 %) for 10 days of culture period. Data represent mean ± S.E.M. *P < 0.05 significantly different
compared to control, ^ P < 0.05 significantly different compared to LPS 24 h (n = 7)
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cell surface markers. Continuous exposure to CSE or LPS
during DC maturation significantly down regulated the
expression of CD11c-MHCII (Fig. 3a and b), and CD40,
CD86 markers (Fig. 3c and d). Next, we tested intracellu-
lar expression of these markers and did not find any signs
of internalization of these receptors (data not shown). At
all-time points of culture, total cell numbers generated per
dish under CSE or LPS condition were not reduced, which
indicates that CSE does not modulate the expansion of
DC precursor cells but rather their maturation.
Furthermore, expression of other monocyte markers
(CD14), macrophages (F4/80) were not detectable (data
not shown). No significant changes in the percentage of
apoptotic and necrotic DCs were found as determined
by using annexin-V and 7-AAD viability staining.
CSE induces DC suppression in a concentration- and time-
dependent manner
To determine whether the suppressive effect of CSE
on DC differentiation is concentration dependent, DC
precursors were cultured prolonged in presence of dif-
ferent concentrations of CSE (0.5–1.5 %) at multiple
time points of culture. The maturation of DCs was sup-
pressed by CSE as revealed by down regulation of CD11c,
MHCII, CD86 and CD40 molecules in concentration-
dependent manner (Fig. 4). In the search for specific CS
constituents, which could be responsible for suppression
of DCs maturation and development, nicotine and acrolein
were tested but none of them mimicked the effect of the
complete CSE (data was not shown).
However, LPS as an important bioactive component of
CSE caused a similar suppression of DC maturation in
long-term co-culture experiments (Fig. 3).
Subsequently, DC precursors were cultured with CSE
continuously for different time periods as described in
Methods (Fig. 1b and c). Co-culture of DCs from day
0–10 with CSE resulted in low expression of cell sur-
face markers (P < 0.05). However, DC undergoing CSE
exposure from day 3 did not show a difference in CD11c-
MHCII expression (Fig. 5). Interestingly, incubation from
Fig. 3 Long-term continuous exposure to CSE suppresses the development of functional DCs from BM precursors. BM precursors were cultured
in the presence or absence of CSE (1.5 %) or LPS (100 ng/ml, as positive control) continuously with every feeding day. Representative dot plots,
(panels a and c) and bars (panels b and d) show percentages of DCs positive for CD11c-MHCII (a, b) CD11c-CD86 and -CD40 (c, d). Data in A and
C show one representative experiment of seven. Data represent mean ± S.E.M. *P < 0.05, **P < 0.01 significantly different compared to control
and ^^ P < 0.01 significantly different compared to LPS 24 h
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day 6 significantly increased the expression of cell surface
markers to the same level as the positive control (LPS)
(Fig. 5). This means, that the effects of CSE are differen-
tially regulated in time.
Time-dependent effect of CSE on cytokine release by DCs
Next, we investigated whether the suppressive effect of
CSE on DCs maturation affected the cytokine produc-
tion. As shown in Fig. 6, the supernatant of DC differen-
tiated in the presence of CSE for 10 days showed no IL-
12, TNF-α and IL-6 production. In contrast, short-term
co-culturing of DCs with CSE or LPS for the final 24 h
resulted in a significant release of these cytokines.
CSE suppressed DC function during prolonged
stimulation for 10 days
Immature DCs efficiently take up antigens and this
function is suppressed after maturation [22]. After co-
culture with CSE during 10 days, the endocytosis ac-
tivity of DCs was measured by FITC-dextran uptake.
The FITC-dextran uptake was reduced in DCs that
were differentiated in the presence of CSE (Fig. 7).
Indeed, maturation of DC’s for 24 h with LPS as a
positive control, showed a decrease in FITC-dextran
uptake. In all experiments, treatments did not affect
cell viability (data not shown).
In a mixed lymphocyte reaction with ovalbumin-
specific D011.10 T cells, DCs cocultured with CSE for
10 days were not able to stimulate CD4 T cell prolif-
eration (see Additional file 1: Figure S1) and cytokine
production. MLR-induced IL-6, IFN-γ, IL12p70 and
IL-10 production was virtually absent when CSE-
cocultured DCs were mixed with CD4 T cells (Fig. 8).
Also proliferation of T cells was greatly reduced with
CSE-cocultured DCs (Additional file 1: Figure S1).
Notably, LPS co-cultured DCs showed significant IL-
6, IL-10 and IFN-γ production. However, this cyto-
kine production was independent of DC:T cell ratio
and may be caused by a direct activation of T cells
by residual LPS.
CSE induced suppression of CD54 on human L428 cells in
a time-dependent manner
The human Hodgkin’s disease (HD)-derived cell line
L428, closely resembles the human DCs phenotype and
function [23, 24]. To determine the effects of CSE on
human DCs, L428 cells were incubated with CSE for 10,
20 and 30 days and the expression of CD54 was mea-
sured. CD54 is an appropriate marker of APCs as well
as an indicator of activation [20]. CSE significantly sup-
pressed the CD54 expression in a time-dependent man-
ner up till day 30 (Fig. 9).
Fig. 4 CSE suppresses DC maturation during long-term stimulation in a concentration-dependent manner. BM precursors were cultured in
presence or absence of CSE (0.5–1.5 %) or LPS (0.01–1 μg/ml, as positive control) continuously with every re-culturing. Representative data
show percentages of DCs positive for CD11c-MHCII (a) CD11c-CD86 (b) and -CD40 (c). Data represent mean ± S.E.M (n = 7). *P < 0.05 significantly
different compared to control,# P < 0.05, ## P < 0.01significantly different compared to CSE 24 h and ≠P < 0.05 significantly different compared
to CSE 0.5 %
Fig. 5 CSE affects the DCs maturation time dependently. Data
show the percentage of CD11c-MHCII-positive DCs. BMDCs were
cultured in with CSE (1.5 %) or LPS (100 ng/ml) continuously for
different periods of time. Data represent mean ± S.E.M (n = 4).
*P < 0.05, **P < 0.01 significantly different compared to control,
^ P < 0.05, ^^P < 0.01 significantly different compared to LPS 24 h,
# P < 0.05significantly different compared to CSE day 0–10 and 6–10
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Discussion
The present study provides evidence that cigarette
smoke can directly modulate the DC-mediated im-
mune response by affecting both function and matur-
ation of DCs. We show that similar to LPS acute/
short-term coculture with CSE stimulates maturation
of newly differentiated and immature DCs, but con-
tinuous/long-term exposure to CSE during DC matur-
ation induces “defective and silent” DCs from BM
precursors. These DCs are characterized by a down
regulation of dendritic cell-specific surface markers,
suppressed antigen uptake, and an impaired capacity
to stimulate T cells and produce cytokines.
Smoking has been shown to alter a wide range of im-
munological responses in both man and animal models.
The effect of cigarette smoke on DC maturation and
function can have important implications in adaptive im-
mune responses in the airways [17, 21, 25]. In the
current study, short-term (18–24 h) coculture of DC
with CSE stimulated immature DCs towards more ma-
ture cells as revealed by upregulation of MHCII, CD83,
CD86, CD40, reduction in antigen up-take capacity and
enhanced secretion of pro-inflammatory IL-12, IL-6 and
TNF-α. These results are in agreement with effects
shown after treatment with nicotine [16] and suggest
that CSE may drive DCs towards full maturation. Expos-
ure to CSE during late stages of development of DCs
(day 6) resulted in the full maturation of DC, even to a
higher level than could be achieved by LPS. On the
other hand, prolonged exposure of BM cells to CSE (for
10 days) causes differentiation of DC precursors into
non-functional DCs. Moreover, similar inhibitory effects
of long-term co-culture with CSE were found on human
L428 cells, which share properties of human DCs result-
ing in a decreased expression of the activation marker
CD54. The phenotypical and functional suppression of
DCs induced by CSE was accompanied by reduced ex-
pression of maturation markers, impaired capacity to
stimulate T cells and produce cytokines. These differen-
tial effects to CSE may suggest that timing of exposure
during the differentiation of DCs may account for the
wide variability observed in studies related to DC matur-
ation and function [14, 16, 26–29].
Our results are in agreement with effects of cigarette
smoke on DCs in mouse models and human subjects.
For example, Robbins et al that cigarette smoke expos-
ure impairs dendritic cell maturation and T cell prolif-
eration in thoracic lymph nodes of mice. They found
that cigarette smoking suppressed DC maturation
within the lymph nodes as demonstrated by reduced
cell surface expression of MHC class II and the
costimulatory molecules CD80 and CD86. DCs from
cigarette smoke-exposed animals had a diminished
capacity to induce IL-2 production by T cells and was
associated with diminished Ag-specific T cell prolifera-
tion in vivo [30]. Furthermore, our recent in vivo
experiments showed that modulation of DC subsets in
acute and chronic models of cigarette smoke-exposed
mice, alters the CS-induce lung inflammation [31].
These findings indicate that cigarette smoke, directly
Fig. 6 CSE suppresses the DCs cytokine responsiveness during long-term stimulation. The culture supernatant from 10 days or last 24 h
CSE-treated DCs were harvested and IL-12, IL-6 and TNF- α cytokines production measured by ELISA. Data represent mean ± S.E.M (n = 7).
*P < 0.05 significantly different compared to control, ^ P < 0.05 significantly different compared to LPS 24 h and # P < 0.05 significantly different
compared to CSE 24 h
Fig. 7 CSE suppresses the FITC-dextran uptake by DCs. The endocytosis
activity of DCs was measured by the FITC-dextran uptake. Data
represent mean ± S.E.M. (n = 4) *P < 0.05 significantly different
compared to control and ^ P < 0.05 significantly different compared
to LPS 24 h
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or indirectly, by inducing inflammation and tissue damage
can trigger activation and differentiation of DCs. In
humans, smoking affects the expression profile of function-
associated surface molecules on airway myeloid DCs and
induces the recruitment of a large numbers of immature
DCs into the small airways of patients with COPD [32–35].
Cigarette smoke contains a complex mixture of chemi-
cals that are capable of exerting immune-modulating
effects. In vitro studies show that CSE and nicotine have
an impact on maturation and function of DCs, which is
accompanied with the suppression of chemokine receptor
expression and the induction of co-stimulatory receptors.
Fig. 8 DCs cocultured with CSE for 10d cannot stimulate T cell activation in a mixed lymphocyte reaction. Ovalbumin-specific D011.10 T cells
were isolated from spleen and mixed with ovalbumin and bone marrow-cultured DCs (untreated), DCs co-cultured with CSE for 10 days (CSE 10d)
or DCs co-cultured for 10 days with LPS (LPS 10 days). Cytokine production was determined in culture supernatant at 72 h
Fig. 9 CSE time-dependently suppressed the CD54 expression on human L428 cell line surface. Cells were cultured in presence or absence of
CSE (1.5 %) or LPS (100 ng/ml, as positive control) continuously with addition of CSE every day during re-culturing for 10, 20 and 30 days.
Representative histograms are showing the cell surface expression of CD54. Data show one representative experiment of three
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However, reported changes in DC function are not coher-
ent [14, 16, 26–29] and may be related to timing and dur-
ation of exposure to cigarette smoke components as
evidenced in this study. In vitro DC cultures may therefore
be useful to gain further insight into the mechanism re-
sponsible for the inhibitory effects of cigarette smoke
components on DC function and consequently their con-
tribution to the vulnerability of COPD patients to viruses
and bacteria.
Conclusions
Our study shows that cigarette smoke has differential ef-
fects on DC’s in vitro. Short term exposure to CSE stim-
ulated maturation of DC generated from mouse bone
marrow cells, while long-term co-culture resulted in
non-functional DCs with an immature phenotype. Pres-
ently, it remains to be investigated if these results can be
translated to effects of cigarette smoking in human air-
ways, but it is tempting to speculate that the observed
effects may contribute to the vulnerability of COPD pa-
tients to viruses and bacteria.
Additional file
Additional file 1: Figure S1. BMDCs (control, CSE co-cultured, or LPS
co-cultured) were mixed with CFSE-labeled DO11.10 T cells (CD4 KJ1-26)
in ratio of 1:10 and 1:20 in the presence of OVA peptide for 72 h. After 72 h
the CSFE dilution profile were analyzed by flow cytometry. (DOCX 196 kb)
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